London, Canada

Todd Hryciw

This inventor holds 1 USPTO granted patent. Top assignees: Arthur Brown, Inc., Critical Outcome Technologies Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Todd Hryciw. Retrieved from https://idiyas.com/inventor/todd-hryciw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Todd Hryciw: Innovator in Peptide Inhibition

Introduction

Todd Hryciw is a notable inventor based in London, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of peptides and compounds that inhibit specific proteins.

Latest Patents

Hryciw holds a patent for "Peptides, Compounds, Compositions and Methods for Inhibiting SOX9." This innovation showcases his expertise in creating solutions that target critical biological pathways.

Career Highlights

Throughout his career, Todd Hryciw has worked with several companies, including Arthur Brown, Inc. and Critical Outcome Technologies Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research.

Collaborations

Hryciw has collaborated with notable individuals in his field, including Arthur Brown and Tony Durst. These partnerships have further enhanced his work and expanded the impact of his inventions.

Conclusion

Todd Hryciw is a distinguished inventor whose work in peptide inhibition has the potential to advance medical science. His contributions reflect a commitment to innovation and collaboration in the biotechnology sector.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…